Aug 21, 2023· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2022-D-2628-0034
CHPA comments on FDA CDRH's draft guidance on "Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning-Enabled Device Software Functions."